Recent

% | $
Quotes you view appear here for quick access.

Zynga, Inc. Message Board

pharmaapproved 214 posts  |  Last Activity: 14 hours ago Member since: Jun 7, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    ooze

    by lwinv10 15 hours ago
    pharmaapproved pharmaapproved 14 hours ago Flag

    "17 brand and generic names" for vbloc SCRATCH THAT.

  • Reply to

    ooze

    by lwinv10 15 hours ago
    pharmaapproved pharmaapproved 14 hours ago Flag

    "Tactics" you are so right.
    I always wondered how someone with no position could spend so much time here. But another poster says ooz may be an Orex investor which could finally explain a few things.The weight loss with vbloc is greater than any of the pills. But about Orex in particular.
    Contrave: BLACK BOX WARNING
    with
    371 major drug interactions (1975 brand and generic names)
    623 moderate drug interactions (3822 brand and generic names)
    6 minor drug interactions (17 brand and generic names)
    =====================================================
    Vbloc: SAFE
    with
    0 major drug interactions
    0 moderate drug interactions
    0 minor drug interactions (17 brand and generic names)

  • pharmaapproved pharmaapproved 15 hours ago Flag

    Oh it's significant.
    also
    Nice to see you finally admit the old data was right after-all. About time you realize why the fda approved the device. Later when the data reveals ewl of 40% and higher today's data will be old data right? The only thing I find disingenuous is why someone who "claims" they have no position in the company would continuously post here.

  • Reply to

    hey ooze and all you other schitte heads

    by innsbrooklad Sep 1, 2015 4:36 PM
    pharmaapproved pharmaapproved Sep 1, 2015 5:11 PM Flag

    well damn hope you start feeling better. The news is stellar, anyone who says it isn't is nuts. I like that the news was released at the International Federation for the Surgery of Obesity and Metabolic Diseases 20th World Congress in Vienna. That should gain some attention where vbloc is approved, Australia, EU, Saudi Arabia, Kuwait, Bahrain, Qatar and the United Arab Emirates. And who knows maybe a oversees partner.

  • Reply to

    hey ooze and all you other schitte heads

    by innsbrooklad Sep 1, 2015 4:36 PM
    pharmaapproved pharmaapproved Sep 1, 2015 4:44 PM Flag

    inns. how is your vacation going?

  • Reply to

    Obesity and Cancer

    by biotia Aug 30, 2015 9:47 AM
    pharmaapproved pharmaapproved Aug 31, 2015 10:38 AM Flag

    Really? So why are you here? Are not looking to make money off the backs of the obese people in the country? I was just pointing out what kids are doing with their lunches. Yes it's a shame kids more importantly adults don't eat right, but it is what it is!

  • Reply to

    Obesity and Cancer

    by biotia Aug 30, 2015 9:47 AM
    pharmaapproved pharmaapproved Aug 31, 2015 10:02 AM Flag

    Murf, there is a follow-up plan with surgery. But as far as people being more aware of what they're putting into their mouths, you just need to look around to see that people are getting fatter not slimmer. And kids today aren't learning anything either. I hear stories all the time of kids throwing away their fruits and vegetables skipping lunches at school only to go home and eat what they like.

  • Reply to

    Obesity and Cancer

    by biotia Aug 30, 2015 9:47 AM
    pharmaapproved pharmaapproved Aug 30, 2015 2:26 PM Flag

    A proper diet? Who does that anymore? I think we should replace proper diet with "eat the foods you like just less of it." and yes exercise always helps but eating less is they key. Then who knows maybe when someone sees themselves losing weight it will give them a little more motivation to exercise. And as I am sure you know with the other procedures you are not going to be able to eat what you like.

    My problem is with the valuation.

  • ct1.medstarhealthDOTorg/content/uploads/sites/13/2015/08/11951-vBloc-Patient-Education-SheetDOTpdf

  • Reply to

    Well, because...

    by oozhe222 Aug 27, 2015 10:14 AM
    pharmaapproved pharmaapproved Aug 27, 2015 12:49 PM Flag

    Inns, I'm getting close to ignoring him considering he said he has no position in the stock. I find that hard to believe though considering he post pretty consistently. Anyway yes as you know the complications where minor heartburn, pain at incision sight which go away after a week or so. Nothing major as this guy would have you believe. As far as price, I really have no idea what the total tally will be. I think it will vary from center to center. But $40,000/$50,000 grand he's nuts!

  • Reply to

    Well, because...

    by oozhe222 Aug 27, 2015 10:14 AM
    pharmaapproved pharmaapproved Aug 27, 2015 11:46 AM Flag

    Gastric Sleeve 13% complication rate
    Gastric Band 13% complication rate
    Gastric Bypass 21% complication rate
    Vbloc 3.7% complication rate

  • pharmaapproved by pharmaapproved Aug 26, 2015 7:30 PM Flag

    "Did you know that your VA was the first VA to perform the vBloc implant procedure for weight loss?"
    Are they suggesting other VA hospitals have started as well?

    facebookDOTcom/VANorthTexas

  • Reply to

    Knudson's Retirement

    by sguceri Aug 25, 2015 8:06 AM
    pharmaapproved pharmaapproved Aug 25, 2015 11:52 AM Flag

    Mark Knudson:
    "I have had the privilege of being involved in numerous companies from conception to generation and have found it particularly rewarding to see EnteroMedics' vBloc Neurometabolic Therapy evolve to where it stands now, available to both patients and physicians who have been waiting over a decade for a new treatment option for obesity and its comorbidities," said Mark B. Knudson, Ph.D., President and Chief Executive Officer. "I am extremely proud of the way we have overcome multiple challenges along the way and of the progress we've made thus far. I feel confident that the company is headed in the right direction. I will continue to lead the organization through the transition and look forward to maintaining my role as Chairman of the Board."

    Jon Tremmel:
    "Dr. Knudson has demonstrated extraordinary leadership throughout his tenure at EnteroMedics," said Jon Tremmel, EnteroMedics Board Member. "Obesity is a disease of epidemic proportion and his incredible vision and perseverance will allow EnteroMedics to become an important part of the solution. We look forward to Mark's continued guidance as we work toward an efficient and smooth transition in the executive role."

  • Reply to

    Knudson's Retirement

    by sguceri Aug 25, 2015 8:06 AM
    pharmaapproved pharmaapproved Aug 25, 2015 9:29 AM Flag

    Well if that is the case I hope the pps moves violently first to the upside. The good news if it is the case I bought a nice chunk at .24 last week.

  • Reply to

    Knudson's Retirement

    by sguceri Aug 25, 2015 8:06 AM
    pharmaapproved pharmaapproved Aug 25, 2015 8:23 AM Flag

    I'm happy to see him step aside although he will still sit on the board.
    What I'm not happy about:
    In recognition of Dr. Knudson's thirteen years of service to the Company, the Board determined to accelerate vesting of all of Dr. Knudson's unvested options as of his retirement and to extend the term during which his options can be exercised for three years after his retirement. Additionally, the Board determined that the Company will provide Dr. Knudson with up to twelve months of post-retirement health care coverage at a cost of approximately $2,000 per month
    Plus
    $5000 to $12,000 a week for consulting services.

  • smarteranalystDOTcom/2015/08/24/enteromedics-incs-etrm-early-commercialization-progress-is-encouraging-canaccord/

  • The Your Weight Matters 4th Annual National Convention August 13-16
    Courtney from EnteroMedics discusses Vbloc.

    positively-healthyDOTcom/ywm2015-new-kids-on-the-vbloc/

  • Reply to

    ETRM needs A CEO, this one has

    by wisetobeme Aug 21, 2015 10:15 AM
    pharmaapproved pharmaapproved Aug 21, 2015 2:25 PM Flag

    August 4, 2015
    United States Patent: 9,095,711
    Systems for regulation of blood pressure and heart rate
    Abstract
    A method and apparatus for treating a condition associated with impaired blood pressure and/or heart rate in a subject comprising applying an electrical treatment signal, wherein the electrical treatment signal is selected to at least partially block nerve impulses, or in some embodiments, to augment nerve impulses.

  • Reply to

    Thoughts

    by jayjasmine Aug 17, 2015 2:15 PM
    pharmaapproved pharmaapproved Aug 18, 2015 12:21 PM Flag

    Gary, There's no doubt you and others where right about the timing for coverage. Where I got it wrong was believing with FDA approval "speculation" would drive us higher. No one seen etrm's bungled offering coming. With that said I gave them a free pass because I believe the technology, what patients are saying and the interest from centers and surgeons from across the country. I also think they're back on track with the different programs they have going on. Still a highly speculative play but I can think of worse companies with nothing to offer who are in far better shape pps wise. Good Luck!!

  • Reply to

    Thoughts

    by jayjasmine Aug 17, 2015 2:15 PM
    pharmaapproved pharmaapproved Aug 18, 2015 9:45 AM Flag

    I agree not only has the access program changed the insurance issue enough to get some coverage, the risk sharing plan will surly help in pulling providers on-board when they realize the cost will be much less than other alternatives. The recent data suggesting other alternatives are very costly post surgery should have vbloc looking pretty rosy.

ZNGA
2.500.00(0.00%)Sep 2 4:00 PMEDT